SCP2

Sterol carrier protein 2 · P22307 · SCP2 on Sugi Atlas →

272 patent compounds predicted against SCP2, 220 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL14267417 SCHEMBL14267417 1.00 1/20
SCHEMBL7812704 SCHEMBL7812704 0.93 1/20
SCHEMBL3501312 SCHEMBL3501312 0.82 1/20
SCHEMBL7815701 SCHEMBL7815701 0.79 1/20
SCHEMBL7812016 SCHEMBL7812016 0.78 1/20
SCHEMBL62370 SCHEMBL62370 0.77 1/20
SCHEMBL4662862 SCHEMBL4662862 0.77 1/20
SCHEMBL19646592 SCHEMBL19646592 0.77 1/20
SCHEMBL26434823 SCHEMBL26434823 0.76 1/20
SCHEMBL13201656 SCHEMBL13201656 0.76 1/20
SCHEMBL26434988 SCHEMBL26434988 0.75 1/20
SCHEMBL61656 SCHEMBL61656 0.75 1/20
SCHEMBL16812947 SCHEMBL16812947 0.74 1/20
SCHEMBL60937 SCHEMBL60937 0.72 1/20
SCHEMBL13182638 SCHEMBL13182638 0.72 1/20
SCHEMBL4664473 SCHEMBL4664473 0.72 1/20
SCHEMBL13881978 SCHEMBL13881978 0.72 1/20
SCHEMBL25188913 SCHEMBL25188913 0.71 1/20
SCHEMBL14267416 SCHEMBL14267416 0.71 1/20
SCHEMBL61937 SCHEMBL61937 0.69 1/20

Clinical trials — most relevant to SCP2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Statin and Ezetimibe Association on Kinetics of Artificial Chilomicrons PHASE4COMPLETED
The Low HDL On Six Weeks Statin Therapy (LOW) Study PHASE4UNKNOWN
Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes PHASE3COMPLETED
Smith-Lemli-Opitz Syndrome and Cholic Acid PHASE1/PHASE2COMPLETED
Comparative Study Between Obeticholic Acid Versus Vitamin E in Patients with Non-alcoholic Steatohepatitis PHASE2ACTIVE_NOT_RECRUITING
Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis PHASE2UNKNOWN
Hereditary Sensory Neuropathy Serine Trial PHASE2UNKNOWN
Epidemiology of Atherosclerosis nanCOMPLETED
Exome Sequencing in Autistic Spectrum Disorder nanCOMPLETED
The Genetic, Protein, and Lipid Basis of Variation in Cholesterol Efflux nanCOMPLETED
Statin Therapy and COVID-19 Infection nanCOMPLETED
Effect of Saturated Fat on Large Low-density Lipoprotein (LDL) and High-density Lipoprotein (HDL) nanCOMPLETED
Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardiovascular Health nanUNKNOWN
The Roles of SAH Gene Family in Athrogenic Dyslipidemia in Postmenopausal Women nanUNKNOWN
Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes nanCOMPLETED
Bile Acids Metabolism and Genetic Mutation Profile in the Intrahepatic Cholestasis of Pregnacy in Indian Population nanRECRUITING
Epigenomic and Metabolomic Signatures of APOA2 Gene by Saturated Fat Interaction nanCOMPLETED
Effect of Laparoscopic Splenectomy on Lipid Profiles in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up) nanNOT_YET_RECRUITING
Gene Expression in Obesity and Insulin Resistance nanCOMPLETED
HIV Reverse Cholesterol Transport Study nanUNKNOWN
Effect of LSD on Lipid Profiles in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up) nanNOT_YET_RECRUITING
In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects nanUNKNOWN
Developing and Implementing Familial Hypercholesterolemia Registry nanUNKNOWN
Genetic Epidemiology of Hypertriglyceridemia nanCOMPLETED
Nutrigenetic Intervention on Blood Lipid Markers and Body Composition of Adults With Overweight and Obesity nanCOMPLETED
Mechanisms of Glucose Lowering Effect of Colesevelam HCl nanCOMPLETED
Effects of Colesevelam HCl On Bile Acid Kinetics nanCOMPLETED
Polycystic Ovary Syndrome in Type 1 Diabetes nanNOT_YET_RECRUITING
Genetic Origin of Lipid Disorders nanUNKNOWN
Genetic and Metabolism of Post-prandial HDL Particles nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SCP2 binder may also engage these)

ProteinNameSimilarity
O62742 1.000 O62742 →
P32020 1.000 P32020 →
P11915 1.000 P11915 →
P07857 1.000 P07857 →
Q07598 1.000 Q07598 →
Q60587 0.990 Q60587 →
Q99JY0 0.990 Q99JY0 →
P27796 0.990 P27796 →
Q5R1W7 0.989 Q5R1W7 →
G5EDP2 0.989 G5EDP2 →
A0AAD6ITA8 0.987 A0AAD6ITA8 →
P34255 0.987 P34255 →
O46629 0.987 O46629 →
HADHB Trifunctional enzyme subunit beta, mitochondrial 0.986 landscape →
A0AAD6NF83 0.986 A0AAD6NF83 →
Q05493 0.986 Q05493 →
A0AAD6NLP7 0.985 A0AAD6NLP7 →
P21775 0.985 P21775 →
Q8HXX4 0.985 Q8HXX4 →
Q570C8 0.984 Q570C8 →
Q8LF48 0.983 Q8LF48 →
Q921H8 0.983 Q921H8 →
P33291 0.983 P33291 →
Q56WD9 0.982 Q56WD9 →
Q39VG1 0.981 Q39VG1 →
P33290 0.981 P33290 →
C8YNG6 0.981 C8YNG6 →
Q5RES5 0.981 Q5RES5 →
O49809 0.981 O49809 →
Q3T0R7 0.981 Q3T0R7 →